Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
12/2000
12/14/2000CA2375876A1 An integrin heterodimer and an alpha subunit thereof
12/14/2000CA2375627A1 Polyepitopic protein fragments of the e6 and e7 proteins of hpv, their production and their use particularly in vaccination
12/14/2000CA2375602A1 Polyepitopic proteinic fragments of the hiv nef protein, production and use thereof in vaccinations
12/14/2000CA2375149A1 Apo-2l receptor agonist and cpt-11 synergism
12/14/2000CA2374851A1 Tek antagonists
12/14/2000CA2374558A1 Phospholipid transfer protein
12/14/2000CA2374256A1 Methods and compounds for the treatment of immunologically-mediated diseases using <i>mycobacterium vaccae</i>
12/14/2000CA2374001A1 Alpha or beta emitters attached to fragments in radioimmunotherapy
12/14/2000CA2371434A1 Compositions and methods for the treatment of tumor
12/13/2000EP1059088A1 New Ig-fractions with immunomodulation activity
12/13/2000EP1058737A1 Novel fdrg protein and nucleic acid molecules and uses therefor
12/13/2000EP1058732A2 Attenuation of bacteria: materials and methods relating thereto
12/13/2000EP1058731A2 Production of mycobacterial polypeptides by lactic acid bacteria
12/13/2000EP1058728A1 V-like domain binding molecules
12/13/2000EP1058726A2 Novel mechanically sensitive mammal potassium channel family activated by polyunsaturated fatty acids and their use particularly for screening medicines
12/13/2000EP1058723A1 Delivery of proteins into eukaryotic cells with recombinant yersinia
12/13/2000EP1058691A1 Caspase-8 interacting proteins
12/13/2000EP1058562A1 Compositions and methods of treating tumors
12/13/2000EP1058558A1 Live recombined vaccines injected with adjuvant
12/13/2000EP1058557A1 Enhancement of immunity by intranasal inoculation of il-12
12/13/2000EP1058555A1 Costimulatory blockade and mixed chimerism in allotransplantation
12/13/2000EP0778781B1 Pneumococcal polysaccharide-recombinant pneumolysin conjugate vaccines for immunization against pneumococcal infections
12/13/2000EP0601062B2 Sirs vaccine and diagnosis method
12/13/2000CN1276834A Modified nucleic acid sequences and method for increasing mRNA level and protein expression in cell system
12/13/2000CN1276833A Vaccine
12/13/2000CN1276831A Modified nucleic acid sequences and method for increasing mRNA levels and protein expression in cell systems
12/13/2000CN1276798A Monoclonal antibody inducing apoptosis
12/13/2000CN1276796A Biomolecules comprising elastomeric peptide
12/13/2000CN1276740A Method for introducing pharmaceutical drugs and nucleic acid into skeletal muscle
12/13/2000CN1276428A Clone and expression of anti-CA125 bifunctional genetically engineered antibody
12/13/2000CN1276245A Vascular endothelial cell heteroimmune vaccine and its preparing process
12/13/2000CN1059466C Method for identifying individuals suffering from cellular abnormality
12/13/2000CN1059347C Process for preparing vaccine for hemorrhagic fever with renal syndrome
12/12/2000US6160108 Platelet activation protein
12/12/2000US6160099 Anti-human αv β3 and αv β5 antibodies
12/12/2000US6160094 Enzymatic polypeptide; for use as a wound healing agent; for use in dentistry to prevent of adhesion of bacteria in wounds
12/12/2000US6160093 Microorganism polypeptide; for the prevention, treatment and diagnosis of microorganismal infection; for use in immunotherapy; anticarcinogenic agents
12/12/2000US6160088 Oligomeric lysine-aspartic acid-glutamic acid-leucine amino acid sequence binding protein suppressor; for amplification of immune response to secreted chaperone proteins
12/12/2000US6160087 Peptides having an amino acid sequence from the fimbrial protein of porphyromonas gingivalis and their uses
12/12/2000US6159949 Polynucleotides, codes and amino acid sequences
12/12/2000US6159947 Isolation of nucleic acids and gene codes
12/12/2000US6159937 Immunomodulators
12/12/2000US6159729 For recombinant production and vaccines
12/12/2000US6159723 Renin-active substance
12/12/2000US6159716 Amino acid sequence of serine/threonine kinase; antiulcer/ anticarcinogenic/antiarthritic agents; treatment of parkinson's/huntigton's diseases, tourette's syndrome, eating disorders, osteoporosis, allergies; diagnosis of disease
12/12/2000US6159712 Methods for enhancing the production of interferon in cell culture
12/12/2000US6159707 Sperm receptors
12/12/2000US6159690 Digesting parent polynucleotide with exonuclease, contacting fragments with template under annealing conditions, then amplifying to generate polynucleotides which encode protein motifs with altered characteristics; enzymes; antibodies
12/12/2000US6159478 Genetic engineering
12/12/2000US6159477 Canine herpesvirus based recombinant live vaccine, in particular against canine distemper, rabies or the parainfluenza 2 virus
12/12/2000US6159472 Intradermal Avian immunization with inactivated vaccines
12/12/2000US6159470 Vaccination and methods against diseases resulting from pathogenic responses by specific T cell populations
12/12/2000US6159463 Lymphocyte chemoattractant factor
12/12/2000US6159443 X-ray guided drug delivery
12/12/2000CA2120506C Treatment of ocular inflammation by blockage of cell adhesion molecules
12/12/2000CA2044721C Preparation and use of enzyme-detergent extracted streptococcus zooepidemicus vaccine
12/12/2000CA1341152C Receptor protein for human b cell stimulatory factor-2
12/09/2000CA2308691A1 Live attenuated bacteria for use in a vaccine
12/07/2000WO2000073801A2 Breast, gastric and prostate cancer associated antigens and uses therefor
12/07/2000WO2000073507A2 Identification of a novel retrovirus associated with primary biliary cirrhosis and autoimmune disorders
12/07/2000WO2000073502A2 Essential genes and gene products for identifying, developing and optimising immunological and pharmacological active ingredients for the treatment of microbial infections
12/07/2000WO2000073500A1 MOLECULAR CHARACTERISATION OF CHROMOSOME TRANSLOCATION t(11;18)(q21;q21) AND ITS CORRELATION TO CARCINOGENESIS
12/07/2000WO2000073487A1 Novel viral vectors having enhanced effectiveness with dramatically reduced virulence
12/07/2000WO2000073476A1 Vector for integration of heterologous sequences into poxviral genomes
12/07/2000WO2000073464A1 Cytotoxic t-cell epitopes of the papillomavirus l1-protein and use thereof in diagnostics and therapy
12/07/2000WO2000073463A1 Groel muteins with improved stability
12/07/2000WO2000073462A2 Attenuated mutant enteropathogenic e. coli (epec) strains, process for their production and their use
12/07/2000WO2000073459A1 Four-helical bundle protein zsig81
12/07/2000WO2000073455A1 Biosynthesis of foreign proteins using transformed microalgae
12/07/2000WO2000073451A1 Mammalian receptor proteins; related reagents and methods
12/07/2000WO2000073450A2 Cytoskeleton-associated proteins
12/07/2000WO2000073449A1 Dna encoding snorf33 receptor
12/07/2000WO2000073445A2 Interleukin-1-receptor associated kinase-3 (irak3)
12/07/2000WO2000073444A1 Adipocyte complement related protein homolog zacrp5
12/07/2000WO2000073438A1 Tumor-associated antigen (c42)
12/07/2000WO2000073432A2 Activation of dendritic cells to enhance immunity
12/07/2000WO2000073415A2 A method for the transfer of antigens to dendritic cells
12/07/2000WO2000073349A1 Dr4 antibodies and uses thereof
12/07/2000WO2000073348A2 Methods and compositions for inhibiting neoplastic cell growth
12/07/2000WO2000073345A2 Antibodies specific for mycobacterial polypeptides and uses thereof
12/07/2000WO2000073344A2 Monoclonal antibodies, synthetic and biotechnological derivatives thereof acting as ngf-antagonist molecules
12/07/2000WO2000073338A1 Compositions and methods for the therapy, diagnosis and monitoring of breast cancer
12/07/2000WO2000073336A1 Fimbrial proteins
12/07/2000WO2000073335A1 Cytotoxic t-cell epitopes of the papilloma virus l1-protein and use thereof in diagnosis and therapy
12/07/2000WO2000073323A2 Adam polynucleotides and polypeptides
12/07/2000WO2000073321A1 Human tumor necrosis factor receptor tr10
12/07/2000WO2000073263A1 Cytofectin dimers and methods of use thereof
12/07/2000WO2000072881A1 A blocking monoclonal antibody to vla-1 and its use for the treatment of inflammatory disorders
12/07/2000WO2000072880A2 Prevention and treatment of amyloidogenic disease
12/07/2000WO2000072876A2 Prevention and treatment of amyloidogenic disease
12/07/2000WO2000072870A1 Compositions of a-beta peptide and processes for producing same
12/07/2000WO2000072855A2 Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria
12/07/2000WO2000046359A3 Medicament
12/07/2000WO2000046147A3 Therapeutic calcium phosphate particles and methods of manufacture and use
12/07/2000WO2000045849A3 Use of cationic lipids to generate anti-tumor immunity
12/07/2000WO2000044410A3 Composition and method for obtaining specific immunisation against one or more antigens using different recombinant vectors
12/07/2000WO2000044392A3 Identification of specific differentially expressed mycobacterial antigens
12/07/2000WO2000043519A3 Neisseria meningitidis polypeptides
12/07/2000WO2000039304A9 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
12/07/2000WO2000037100A3 Compositions and methods for reducing or preventing fertilization in fish and birds
1 ... 1444 1445 1446 1447 1448 1449 1450 1451 1452 1453 1454 1455 1456 1457 1458 1459 1460 1461 1462 1463 1464 ... 1823